KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to -$359.0 million.

  • Bristol Myers Squibb's Deferred Taxes fell 4023.44% to -$359.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.4 billion, marking a year-over-year increase of 4803.81%. This contributed to the annual value of -$2.1 billion for FY2024, which is 3646.59% up from last year.
  • Latest data reveals that Bristol Myers Squibb reported Deferred Taxes of -$359.0 million as of Q3 2025, which was down 4023.44% from -$437.0 million recorded in Q2 2025.
  • Bristol Myers Squibb's Deferred Taxes' 5-year high stood at $223.0 million during Q1 2025, with a 5-year trough of -$1.3 billion in Q4 2023.
  • Its 5-year average for Deferred Taxes is -$530.6 million, with a median of -$548.0 million in 2023.
  • As far as peak fluctuations go, Bristol Myers Squibb's Deferred Taxes skyrocketed by 22830.19% in 2021, and later plummeted by 191562.5% in 2022.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Deferred Taxes stood at -$1.3 billion in 2021, then skyrocketed by 50.71% to -$624.0 million in 2022, then plummeted by 112.66% to -$1.3 billion in 2023, then surged by 40.39% to -$791.0 million in 2024, then surged by 54.61% to -$359.0 million in 2025.
  • Its last three reported values are -$359.0 million in Q3 2025, -$437.0 million for Q2 2025, and $223.0 million during Q1 2025.